Investor Presentaiton

80 Eyes diagnosed with Glaucoma Rest of World Market Opportunity 20.0 15.0 Major growth by 13.4 M expanding penetration 10.0 in moderate patients 5.0 20.6 M 1.4 M 0.6 M 0.0 Severe Advanced (3+) Moderate (2-3) Mild (0-1) GLAUCOMA SPECIALIST *Market Scope and Company estimates COMPREHENSIVE Our ROW 2019 MP3 volume: 25K run rate Our ROW 2019 installed systems: 900 4.5 million target eyes in developed economies o 3,000 Glaucoma specialists 25,000 Cataract surgeons performing glaucoma procedures $700 million ROW probe opportunity $50M probe revenue is 7% ROW penetration IRIDEX

View entire presentation